Cameco (CCJ) is a core holding, delivering consistent alpha and benefiting from disciplined supply management and vertical integration in the nuclear fuel cycle. CCJ's high-grade uranium assets, strategic Westinghouse stake, and global nuclear energy resurgence position it for sustained earnings and market leadership. Recent financials show robust growth: 2025 revenue of $3.48B (+11% YoY), net income up 240%, and Q1 2026 adjusted EBITDA of $509M.
Cameco (CCJ) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.11 per share a year ago.
In the most recent trading session, Cameco (CCJ) closed at $120.43, indicating a -2.13% shift from the previous trading day.
CCJ nears Q1 results with lower uranium volumes but higher prices, pointing to earnings growth despite softer revenues and a low likelihood of a beat.
Cameco (CCJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In the most recent trading session, Cameco (CCJ) closed at $122.15, indicating a -1.37% shift from the previous trading day.
This uranium miner is well-positioned to reward investors for years to come.
Nuclear energy is on the rise, and Cameco and Oklo could benefit.
Cameco (CCJ) closed at $116.61 in the latest trading session, marking a -5.67% move from the prior day.
Cameco vs. Energy Fuels: One offers scale and stability, while the other offers rapid growth, improving costs and REE expansion. Here's how the uranium rivals stack up.
Cameco (NYSE:CCJ) stock just earned a strong endorsement from William Blair, which initiated coverage with an Outperform rating and a $165 fair value estimate.
Cameco Corporation CCJ had reported 26% year-over-year increase in its adjusted EBITDA to CAD 1.93 billion ($1.41 billion) in 2025. This was driven mainly by the uranium segment and higher earnings from Westinghouse.